Recursion Details AI-First Path from Target Mapping to Clinic
Recursion Pharmaceuticals executives outlined how the company's machine learning-driven platform is applied across target identification, molecule design and clinical development. Management described large-scale experimental datasets, partnership-supplemented data capacity, concrete examples of compressed timelines and early-stage cost reduction e…